Monday, 24th April 2017 17:16:48 GMT+0530
Ad Here

Recent News

Sphaera receives Notice of Allowance from United States Patent and Trademark Office for Novel Triazine Compounds.

Patent published from USPTO for Drug Modification Technology.

Sphaera Pharma announces the successful completion of the first milestone of the MDR/ XDR TB project.

Notice of Allowance from the United States Patent and Trademark Office for Sphaera Pharma’s Drug Modification Platform technology

Sphaera Pharma, THSTI and Wellcome Trust collaborating to develop a novel treatment for Drug Resistant Tuberculosis

Recent News